Skip to main content
SpringerLink
Log in

The therapeutic and diagnostic cardiac electrophysiological uses of adenosine

  • Review: Cardiac Electrophysiology
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Summary

Adenosine is a purine nucleoside with a rapid onset and brief duration of action after intravenous bolus administration. Its most prominent cardiac effect is impairment or blockade of atrioventricular nodal conduction, but other effects are depression of automaticity of the sinus node and attenuation of catecholamine-related ventricular after-depolarizations. The cardiac cell surface receptor is the A1 purinoceptor. The therapeutic value of adenosine is predominantly in those arrhythmias in which the atrioventricular node forms part of a reentry circuit, as clearly demonstrated by the high success rate for termination of atrioventricular nodal reentry tachycardia and of atrioventricular reentry tachycardia involving an accessory pathway in the Wolff-Parkinson-White syndrome. Ventricular tachycardias are generally unresponsive, with the exception of right ventricular outflow tract tachycardia. A diagnostic role has emerged for adenosine. The transient blockade of the atrioventricular node that it causes can reveal important electrocardiographic features in arrhythmias, such as atrial flutter, or can unmask latent preexcitation. In wide-QRS tachycardias, adenosine can help to distinguish ventricular tachycardia from supraventricular tachycardia with QRS aberration. Unlike verapamil, adenosine is safe in ventricular tachycardia. A suggested dosing scheme is to give incremental doses at 1-minute intervals, starting at 0.05 mg/kg and continuing until complete atrioventricular block is induced or a maximum of 0.25 mg/kg is reached. Side effects are transient, sometimes uncomfortable, and not hazardous; dyspnea and chest discomfort are most frequent. A history of asthma is a relative contraindication. Aminophylline antagonizes and dipyridamole potentiates the effects of adenosine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. DiMarco JP, Sellers TD, Berne RM, et al. Adenosine: electrophysiologic effects and therapeutic use for terminating paroxysmal supraventricular tachycardia.Circulation 1983;68:1254–1263

    PubMed  Google Scholar 

  2. Belhassen B, Pelleg A. Acute management of paroxysmal supraventricular tachycardia: verapamil, adenosine triphosphate or adenosine?Am J Cardiol 1984;54:225–227.

    PubMed  Google Scholar 

  3. DiMarco JP, Sellers TD, Lerman BB, et al. Diagnostic and therapeutic use of adenosine in patients with supraventricular tachyarrhythmias.J Am Coll Cardiol 1985;6:417–425.

    PubMed  Google Scholar 

  4. Garratt C, Linker N, Griffith M, et al. Comparison of adenosine and verapamil for termination of paroxysmal junctional tachycardia.Am J Cardiol 1989;64:1310–1316.

    PubMed  Google Scholar 

  5. Rankin AC, Oldroyd KG, Chong E, et al. Value and limitations of adenosine in the diagnosis and treatment of narrow and broad complex tachycardias.Br Heart J 1989;62:195–203.

    PubMed  Google Scholar 

  6. Till J, Shinebourne EA, Rigby ML, et al. Efficacy and safety of adenosine in the treatment of supraventricular tachycardia in infants and children.Br Heart J 1989;62:204–211.

    PubMed  Google Scholar 

  7. DiMarco JP, Miles W, Akhtar M, et al. Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil. Assessment in placebo-controlled, multicenter trials.Ann Intern Med 1990;113:104–110.

    PubMed  Google Scholar 

  8. Rankin AC, Oldroyd KG, Chong E, et al. Adenosine or adenosine triphosphate for supraventricular tachycardias? Comparative double-blind randomized study in patients with spontaneous or inducible arrhythmias.Am Heart J 1990;119:316–323.

    PubMed  Google Scholar 

  9. Drury AN, Szent-Györgyi A. The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart.J Physiol (Lond) 1929;68:213–237.

    Google Scholar 

  10. James TN. The chronotropic action of ATP and related compounds studied by direct perfusion of the sinus node.J Pharmacol Exp Ther 1965;149:233–247.

    PubMed  Google Scholar 

  11. Pelleg A. Cardiac cellular electrophysiologic actions of adenosine and adenosine triphosphate.Am Heart J 1985;110:688–693.

    PubMed  Google Scholar 

  12. Puech P, Munoz A, Sassine A, et al. Use of adenosine as an antiarrhythmic agent. In: Vaughan Williams EM, ed.Antiarrhythmic drugs, handbook of experimental pharmacology 89. Berlin: Springer-Verlag, 1989:453–460.

    Google Scholar 

  13. Belardinelli L, Lerman BB. Electrophysiological basis for the use of adenosine in the diagnosis and treatment of cardiac arrhythmias.Br Heart J 1990;63:3–4.

    PubMed  Google Scholar 

  14. Belardinelli L, Linden J, Berne RM. The cardiac effects of adenosine.Prog Cardiovasc Dis 1990;32:73–97.

    Google Scholar 

  15. Faulds D, Chrisp P, Buckley MM-T. Adenosine: an evaluation of its use in cardiac diagnostic procedures, and in the treatment of paroxysmal supraventricular tachycardia.Drugs 1991;41:596–624.

    PubMed  Google Scholar 

  16. Garratt CJ, Griffith MJ, O'Nunain S, et al. Effects of intravenous adenosine on antegrade refractoriness of accessory atrioventricular connections.Circulation 1991;84:1962–1968.

    PubMed  Google Scholar 

  17. Szentmiklósi AJ, Németh M, Cseppentö Á, et al. Potentiation of the myocardial actions of adenosine in the presence of coformycin, a specific inhibitor of adenosine deaminase.Arch Int Pharmacodyn 1982;256:236–252.

    PubMed  Google Scholar 

  18. Munoz A, Leenhardt A, Sassine A, et al. Therapeutic use of adenosine for terminating spontaneous paroxysmal supraventricular tachycardia.Eur Heart J 1984;5:735–738.

    PubMed  Google Scholar 

  19. Burnstock G. Purinergic receptors in the heart.Circ Res 1980;46(Suppl I):175–182.

    PubMed  Google Scholar 

  20. Olsson RA, Pearson JD. Cardiovascular purinoceptors.Physiol Rev 1990;70:761–845.

    PubMed  Google Scholar 

  21. Ralevic V, Burnstock G. Roles of P2-purinoceptors in the cardiovascular system.Circulation 1991;84:1–14.

    PubMed  Google Scholar 

  22. Mehta D, Wafa S, Ward DE, Camm AJ. Relative efficacy of various physical manoeuvres in the termination of junctional tachycardia.Lancet 1988;1:1181–1185.

    PubMed  Google Scholar 

  23. Clarke B, Till J, Rowland E, et al. Rapid and safe termination of supraventricular tachycardia in children by adenosine.Lancet 1987;1:299–301.

    PubMed  Google Scholar 

  24. Rossi AF, Kipel G, Golinko RJ, et al. Use of adenosine in postoperative junctional ectopic tachycardia with 1:1 retrograde atrial conduction.Am Heart J 1991;121:1237–1239.

    PubMed  Google Scholar 

  25. Lerman BB, Belardinelli L, West A, et al. Adenosinesensitive ventricular tachycardia: evidence suggesting cyclic AMP-mediated triggered activity.Circulation 1986;74:270–280.

    PubMed  Google Scholar 

  26. Griffith MJ, Garratt CJ, Rowland E, et al. Verapamil sensitive ventricular tachycardia: effects of vagal manoeuvres and adenosine (abstr).Br Heart J 1990;64:86–87.

    Google Scholar 

  27. Ward DE, Camm AJ. Ventricular tachycardia. In:Clinical electrophysiology of the heart. London: Edward Arnold, 1987:213–254.

    Google Scholar 

  28. Griffith MJ, Linker NJ, Ward DE, et al. Adenosine in the diagnosis of broad complex tachycardia.Lancet 1988;1:672–675.

    PubMed  Google Scholar 

  29. Spurrell RAJ, Krikler DM, Sowton E. Concealed bypasses of the atrioventricular node in patients with paroxysmal supraventricular tachycardia revealed by intracardiac electrical stimulation and verapamil.Am J Cardiol 1974;33:590–595.

    PubMed  Google Scholar 

  30. Farshidi A, Josephson ME, Horowitz LN. Electrophysiologic characteristics of concealed bypass tracts: clinical and electrocardiographic correlates.Am J Cardiol 1978;41:1052–1060.

    PubMed  Google Scholar 

  31. Klein GJ, Galamhusein SS. Intermittent preexcitation in the Wolff-Parkinson-White syndrome.Am J Cardiol 1983;52:292–296.

    PubMed  Google Scholar 

  32. Gallagher JJ, Pritchett ELC, Sealy WC, et al. The preexcitation syndromes.Prog Cardiovasc Dis 1978;20:285–327.

    PubMed  Google Scholar 

  33. Robinson K, Rowland E, Krikler DM. Latent pre-excitation: exposure of anterograde accessory pathway conduction during atrial fibrillation.Br Heart J 1988;59:53–55.

    PubMed  Google Scholar 

  34. Garratt CJ, Antoniou A, Griffith MJ, et al. Use of intravenous adenosine in sinus rhythm as a diagnostic test for latent preexcitation.Am J Cardiol 1990;65:868–873.

    PubMed  Google Scholar 

  35. Butrous GS, Cochrane T, Camm AJ. Rapid autonomic tone regulation of atrioventricular nodal conduction in man.Am Heart J 1987;113:934–940.

    PubMed  Google Scholar 

  36. Berk WA, Shea MJ, Crevey BJ. Bradycardic responses to vagally mediated bedside maneuvres in healthy volunteers.Am J Med 1991;90:725–729.

    PubMed  Google Scholar 

  37. Benedini G, Cuccia C, Bolognesi R, et al. Value of purinic compounds in assessing sinus node dysfunction in man: a new diagnostic method.Eur Heart J 1984;5:394–403.

    PubMed  Google Scholar 

  38. Watt AH, Lewis DJM, Horne JJ, et al. Reproduction of epigastric pain of duodenal ucleration by adenosine.Br Med J 1987;294:10–12.

    Google Scholar 

  39. Sylvén C, Jonzon B, Brandt R, et al. Adenosine-provoked angina pectoris-like pain—time characteristics, influence of autonomic blockade and naloxone.Eur Heart J 1987;8:738–743.

    PubMed  Google Scholar 

  40. Sylvén C, Jonzon B, Edlund A. Angina pectoris-like pain provoked by i.v. bolus of adenosine: relationship to coronary sinus blood flow, heart rate and blood pressure in healthy volunteers.Eur Heart J 1989;10:48–54.

    Google Scholar 

  41. Crea F, Pupita G, Galassi AR, et al. Role of adenosine in the pathogenesis of anginal pain.Circulation 1990;81:164–172.

    PubMed  Google Scholar 

  42. Gaspardone A, Crea F, Tomai F, et al. Algogenic effect of the intra-femoral infusion of adenosine (abstr).J Am Coll Cardiol 1992;19:330A.

    Google Scholar 

  43. Biaggioni I, Olafsson B, Robertson RM, et al. Cardiovascular and respiratory effects of adenosine in conscious man; evidence for chemoreceptor activation.Circ Res 1987;61:779–786.

    PubMed  Google Scholar 

  44. Cushley MJ, Tattersfield AE, Holgate ST. Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects.Br J Clin Pharmacol 1983;15:161–165.

    PubMed  Google Scholar 

  45. Taviot B, Pacheco Y, Coppere B, et al. Bronchospame induit par l'injection d'adénosine chez un asthmatique.Presse Med 1986;15:1103.

    Google Scholar 

  46. Nunain SO, Garratt C, Paul V, et al. Effects of adenosine on monophasic action potential in humans (abstr).Br Heart J. 1991;66:81.

    Google Scholar 

  47. Cerbai E, Klockner U, Isenberg G. Ca-antagonistic effects of adenosine in guinea pig atrial cells.Am J Physiol 1988;255:H872-H878.

    PubMed  Google Scholar 

  48. Kolassa N, Pfleger K, Rummel W. Specificity of adenosine uptake into the heart and inhibition by dipyridamole.Eur J Pharmacol 1970;9:265–268.

    PubMed  Google Scholar 

  49. Watt AH, Bernard MS, Webster J, et al. Intravenous adenosine in the treatment of supraventricular tachycardia: a dose-ranging study and interaction with dipyridamole.Br J Clin Pharmacol 1986;21:227–230.

    PubMed  Google Scholar 

  50. Stewart RB, Bardy GH, Greene HL. Wide complex tachycardia: misdiagnosis and outcome after emergent therapy.Ann Intern Med 1986;104:766–771.

    PubMed  Google Scholar 

  51. Rankin AC, Rae AP, Cobbe SM. Misuse of intravenous verapamil in patients with ventricular tachycardia.Lancet 1987;2:472–474.

    PubMed  Google Scholar 

  52. Gulamhusein S, Ko P, Carruthers SG, et al. Acceleration of the ventricular response during atrial fibrillation in the Wolff-Parkinson-White syndrome after verapamil.Circulation 1982;65:348–354.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiological Sciences, St. George's Hospital Medical School, SW17 ORE, London, England

    Alasdair D. Malcolm, Clifford J. Garratt & A. John Camm

Authors
  1. Alasdair D. Malcolm
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Clifford J. Garratt
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. John Camm
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Malcolm, A.D., Garratt, C.J. & Camm, A.J. The therapeutic and diagnostic cardiac electrophysiological uses of adenosine. Cardiovasc Drug Ther 7, 139–147 (1993). https://doi.org/10.1007/BF00878323

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00878323

Key Words

Search

Navigation